UCLA study sheds light on how advanced melanoma resists treatment
Findings are a promising step toward developing improved treatments for the disease
UCLA researchers have identified mechanisms that determine how advanced melanoma can become resistant to immune checkpoint inhibitors, a discovery that could lead to the development of new and improved treatments for the deadliest type of skin cancer. (more…)